Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
202.5 USD | +0.23% | +6.27% | -21.76% |
Apr. 25 | Goldman Sachs Adjusts Biogen Price Target to $340 From $393 | MT |
Apr. 25 | Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.76% | 29.36B | |
-4.78% | 87.31B | |
+2.63% | 40.86B | |
+58.56% | 24.49B | |
-14.78% | 17.31B | |
-18.49% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B | |
-8.30% | 7.9B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : Wedbush Adjusts Price Target for Biogen to $297 From $314, Maintains Neutral Rating